Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-001212
Filing Date
2011-01-04
Accepted
2011-01-04 17:52:20
Documents
1
Period of Report
2011-01-01

Document Format Files

Seq Description Document Type Size
1 BLUTT MITCHELL J-- FORM 4 rrd295815.html 4  
1 BLUTT MITCHELL J-- FORM 4 rrd295815.xml 4 6003
  Complete submission text file 0001181431-11-001212.txt   7940
Mailing Address 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM CA 92807
Business Address 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM CA 92807 714-820-4500
QUESTCOR PHARMACEUTICALS INC (Issuer) CIK: 0000891288 (see all company filings)

EIN.: 330476164 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address JPMORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020
Business Address
BLUTT MITCHELL J MD (Reporting) CIK: 0001097955 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14758 | Film No.: 11507735